111 related articles for article (PubMed ID: 11290867)
1. Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Thurnher D; Kornfehl J; Burian M; Gedlicka C; Selzer E; Quint C; Neuchrist C; Kornek GV
Anticancer Drugs; 2001 Mar; 12(3):205-8. PubMed ID: 11290867
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Shin DM; Khuri FR; Glisson BS; Ginsberg L; Papadimitrakopoulou VM; Clayman G; Lee JJ; Ang KK; Lippman SM; Hong WK
Cancer; 2001 Apr; 91(7):1316-23. PubMed ID: 11283932
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of high-dose ifosfamide as a single agent and in combination with cisplatin in the treatment of advanced and/or recurrent squamous cell carcinoma of head and neck.
Pai VR; Parikh DM; Mazumdar AT; Rao RS
Oncology; 1993; 50(2):86-91. PubMed ID: 8451041
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
[TBL] [Abstract][Full Text] [Related]
6. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.
Cervellino JC; Araujo CE; Pirisi C; Francia A; Cerruti R
Oncology; 1991; 48(2):89-92. PubMed ID: 1900124
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
Huber MH; Lippman SM; Benner SE; Shirinian M; Dimery IW; Dunnington JS; Hong WK
Am J Clin Oncol; 1996 Aug; 19(4):379-82. PubMed ID: 8677909
[TBL] [Abstract][Full Text] [Related]
10. Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
Recchia F; Lalli A; Lombardo M; De Filippis S; Saggio G; Fabbri F; Rosselli M; Capomolla E; Rea S
Cancer; 2001 Aug; 92(4):814-21. PubMed ID: 11550152
[TBL] [Abstract][Full Text] [Related]
11. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
[TBL] [Abstract][Full Text] [Related]
13. Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gedlicka C; Formanek M; Selzer E; Burian M; Kornfehl J; Fiebiger W; Cartellieri M; Marks B; Kornek GV
Oncology; 2002; 63(2):145-50. PubMed ID: 12239449
[TBL] [Abstract][Full Text] [Related]
14. Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Kornek V; Scheithauer W; Glaser C; Toth J; Duman M; Formanek M; Hejna M; Kornfehl J
Oncology; 1999; 56(1):24-7. PubMed ID: 9885373
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignancies.
Gedlicka C; Schüll B; Formanek M; Kornfehl J; Burian M; Knerer B; Selzer E; Scheithauer W; Kornek GV
Anticancer Drugs; 2002 Jun; 13(5):491-5. PubMed ID: 12045460
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck: a phase II Hoosier Oncology Group trial.
Sandler A; Saxman S; Bandealy M; Heilman D; Monaco F; McClean J; Arquette M
Am J Clin Oncol; 1998 Apr; 21(2):195-7. PubMed ID: 9537211
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of ifosfamide in recurrent and metastatic head and neck cancer.
Buesa JM; Fernández R; Esteban E; Estrada E; Barón FJ; Palacio I; Gracia M; Lacave AJ
Ann Oncol; 1991 Feb; 2(2):151-2. PubMed ID: 1905150
[TBL] [Abstract][Full Text] [Related]
19. A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer.
Nardi M; Della Giulia M; Pollera CF; Marolla P; Ruggeri EM; Iacovelli A; Atlante G; Calabresi F
Cancer Chemother Pharmacol; 1996; 38(3):298-301. PubMed ID: 8646807
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.
Graziano SL; Herndon JE; Richards F; DiFino S; Modeas C; Duggan DB; Green MR
Cancer; 1993 Jul; 72(1):62-8. PubMed ID: 8389667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]